Literature DB >> 2391520

High incidence of endogenous depression in migraine: confirmation by tyramine test.

J Jarman1, M Fernandez, P T Davies, V Glover, T J Steiner, C Thompson, F C Rose, M Sandler.   

Abstract

Forty patients with migraine who were attending a specialist clinic were interviewed with the Schedule for Affective Disorders and Schizophrenia--Lifetime version. Sixteen (40%) had a history of major depression which was of endogenous type in 15, according to Research Diagnostic Criteria. The tyramine test, a previously established trait marker for endogenous depression, showed that the migraine group as a whole had significantly low values compared with 14 normal controls, due almost entirely to low values in the endogenous depressive subgroup; there were no differences between diet-sensitive and non-diet-sensitive migraine patients. Thus depression in patients with migraine seems unlikely to be secondary to migraine per se. A substantial subgroup of patients with migraine may possess an inherent predisposition to endogenous depression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391520      PMCID: PMC488132          DOI: 10.1136/jnnp.53.7.573

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  Migraine in children.

Authors:  B VAHLQUIST
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

2.  Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects.

Authors:  J R Couch; D K Ziegler; R Hassanein
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

3.  Psychological aspects of migraine.

Authors:  R Henryk-Gutt; W L Rees
Journal:  J Psychosom Res       Date:  1973-03       Impact factor: 3.006

4.  Headache and psychiatric disorders.

Authors:  T Kashiwagi; J N McClure; R D Wetzel
Journal:  Dis Nerv Syst       Date:  1972-10

5.  Effectiveness of methysergide in relation to clinical features of migraine.

Authors:  P D Drummond
Journal:  Headache       Date:  1985-05       Impact factor: 5.887

6.  Tyramine conjugation test for prediction of treatment response in depressed patients.

Authors:  A S Hale; M Sandler; P Hannah; P K Bridges
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

7.  The tyramine challenge test as a marker for melancholia.

Authors:  W M Harrison; T B Cooper; J W Stewart; F M Quitkin; P J McGrath; M R Liebowitz; J R Rabkin; J S Markowitz; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1984-07

8.  Tyramine-conjugation deficit as a trait-marker in endogenous depressive illness.

Authors:  A S Hale; P L Walker; P K Bridges; M Sandler
Journal:  J Psychiatr Res       Date:  1986       Impact factor: 4.791

9.  The analysis of urinary meta- and para-tyramine by gas chromatography with electron-capture detection.

Authors:  P L Walker; M Sandler
Journal:  Ann Clin Biochem       Date:  1988-05       Impact factor: 2.057

10.  Migraine and depression: association and familial transmission.

Authors:  K R Merikangas; N J Risch; J R Merikangas; M M Weissman; K K Kidd
Journal:  J Psychiatr Res       Date:  1988       Impact factor: 4.791

View more
  4 in total

1.  Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study.

Authors:  Deborah A Stokes; Martha S Lappin
Journal:  Behav Brain Funct       Date:  2010-02-02       Impact factor: 3.759

2.  Anxiety and depression in migraine.

Authors:  J Devlen
Journal:  J R Soc Med       Date:  1994-06       Impact factor: 5.344

Review 3.  Migraine and psychiatric comorbidity: a review of clinical findings.

Authors:  Fabio Antonaci; Giuseppe Nappi; Federica Galli; Gian Camillo Manzoni; Paolo Calabresi; Alfredo Costa
Journal:  J Headache Pain       Date:  2011-01-06       Impact factor: 7.277

4.  Psychiatric comorbidities of chronic migraine in community and tertiary care clinic samples.

Authors:  Antonio Lucio Teixeira; Esther Angélica Coelho Costa; Ariovaldo Alberto da Silva; Igor Alvarenga Moreira dos Santos; Rodrigo Santiago Gómez; Arthur Kummer; Edward C Lauterbach
Journal:  J Headache Pain       Date:  2012-09-01       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.